|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Chiche J, Brahimi-Horn MC and Pouysségur
J: Tumor hypoxia induces a metatloic shift causing acidosis: a
common feature in cancer. J Cell Mol Med. 14:771–794. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Trédan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007.
|
|
4
|
Subarsky P and Hill RP: The hypoxic tumour
microenvironment and metastatic progression. Clin Exp Metastasis.
20:237–250. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sennoune SR, Bakunts K, Martinez GM, et
al: Vacuolar H+-ATPase in human breast cancer cells with
distinct metastatic potential: distribution and functional
activity. Am J Physiol Cell Physiol. 286:1443–1452. 2004.
|
|
6
|
Lu X, Qin W, Li J, et al: The growth and
metastasis of human hepatocellular carcinoma xenografts are
inhibited by small interfering RNA targeting to the subunit ATP6L
of proton pump. Cancer Res. 65:6843–6849. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martinez-Zaguilan R, Lynch RM, Martinez GM
and Gillies RJ: Vacuolar-type H(+)-ATPases are functionally
expressed in the plasma membranes of human tumor cells. Am J
Physiol. 265:C1015–C1029. 1993.
|
|
8
|
Fais S, De Milito A, You HY and Qin W:
Targeting vacuolar H+-ATPases as a new strategy against
cancer. Cancer Res. 67:10627–10630. 2007.PubMed/NCBI
|
|
9
|
Barrison AF, Jarboe LA, Weinberg BM, et
al: Patterns of proton pump inhibitor use in clinical practice. Am
J Med. 111:469–473. 2011. View Article : Google Scholar
|
|
10
|
Chen M, Zou XP, Luo HS, et al: Effects and
mechanisms of proton pump inhibitors as a novel chemosensitizer on
human gastric adenocarcinoma (SGC7901) cells. Cell Biol Int.
33:1008–1019. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peifer M and Polakis P: Wnt signaling in
oncogenesis and embryogenesis - a look outside the nucleus.
Science. 287:1606–1609. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nishi T and Forgac M: The vacuolar
(H+)-ATPases - nature's most versatile proton pumps. Nat Rev Mol
Cell Biol. 3:94–103. 2002.
|
|
13
|
Swietach P, Vaughan-Jones RD and Harris
AL: Regulation of tumor pH and the role of carbonic anhydrase 9.
Cancer Metastasis Rev. 26:299–310. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sennoune SR, Luo D and Martínez-Zaguilán
R: Plasmalemmal vacuolar-type H+-ATPase in cancer
biology. Cell Biochem Biophys. 40:185–206. 2004. View Article : Google Scholar
|
|
15
|
De Milito A, Canese R, Marino ML, et al:
pH-dependent antitumor activity of proton pump inhibitors against
human melanoma is mediated by inhibition of tumor acidity. Int J
Cancer. 127:207–219. 2009.PubMed/NCBI
|
|
16
|
Luciani F, Spada M, De Milito A, et al:
Effect of proton pump inhibitor pretreatment on resistance of solid
tumors to cytotoxic drugs. J Natl Cancer Inst. 96:1702–1713. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yeo M, Kim DK, Kim YB, et al: Selective
induction of apoptosis with proton pump inhibitor in gastric cancer
cells. Clin Cancer Res. 10:8687–8696. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
De Milito A, Iessi E, Logozzi M, et al:
Proton pump inhibitors induce apoptosis of human B-cell tumors
through a caspase-independent mechanism involving reactive oxygen
species. Cancer Res. 67:5408–5417. 2007.PubMed/NCBI
|
|
19
|
Bowman EJ, Siebers A and Altendorf K:
Bafilomycins: a class of inhibitors of membrane ATPases from
microorganisms, animal cells, and plant cells. Proc Natl Acad Sci
USA. 85:7972–7976. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Melikova MS, Blagoveshchenskaia AD,
Nikol’skiĭ NN and Kornilova ES: Effect of an vacuolar proton pump
inhibitor bafilomycin A1 on the intracellular processing of markers
for receptor-mediated and liquid phase endocytosis. Tsitologiia.
44:807–816. 2002.(In Russian).
|
|
21
|
Petrangolini G, Supino R, Pratesi G, et
al: Effect of a novel vacuolar-H+-ATPase inhibitor on
cell and tumor response to camptothecins. J Pharmacol Exp Ther.
318:939–946. 2006.PubMed/NCBI
|
|
22
|
Niikura K: Effect of a V-ATPase inhibitor,
FR202126, in syngeneic mouse model of experimental bone metastasis.
Cancer Chemother Pharmacol. 60:555–562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hesselink RW, Fedorov A, Hemminga MA and
Prieto M: Membrane-bound peptides from V-ATPases subunit a do not
interact with an indole-type inhibitor. J Pept Sci. 14:383–388.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.
|
|
25
|
Korinek V, Barker N, Morin PJ, et al:
Constitutive transcriptional activation by a β-catenin-Tcf complex
in APC-/-colon carcinoma. Science. 275:1784–1787. 1997.
|
|
26
|
Rubinfeld B, Robbins P, El-Gamil M, et al:
Stabilization of β-catenin by genetic defects in melanoma cell
lines. Science. 275:1790–1792. 1997.
|
|
27
|
Satoh S, Daigo Y, Furukawa Y, et al: AXIN1
mutations in hepatocellular carcinomas, and growth suppression in
cancer cells by virus mediated transfer of AXIN1. Nat Genet.
24:245–250. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
de La Coste A, Romagnolo B, Billuart P, et
al: Somatic mutations of the β-catenin gene are frequent in mouse
and human hepatocellular carcinomas. Proc Natl Acad Sci USA.
95:8847–8851. 1998.
|
|
29
|
Merle P, de la Monte S, Kim M, et al:
Functional consequences of frizzled-7 receptor overexpression in
human hepatocellular carcinoma. Gastroenterology. 127:1110–1122.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cruciat CM, Ohkawara B, Acebron SP, et al:
Requirement of prorenin receptor and vacuolar
H+-ATPase-mediated acidification for Wnt signaling.
Science. 327:459–463. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Blitzer JT and Nusse R: A critical role
for endocytosis in Wnt signaling. BMC Cell Biol. 7:282006.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yamamoto H, Komekado H and Kikuchi A:
Caveolin is necessary for Wnt-3a-dependent internalization of LRP6
and accumulation of β-catenin. Dev Cell. 11:213–223.
2006.PubMed/NCBI
|
|
33
|
Wang J, Wang X, Gong W, et al: Increased
expression of β-catenin, phosphorylated glycogen synthase kinase
3β, cyclin D1, and c-myc in laterally spreading colorectal
tumors. J Histochem Cytochem. 57:363–371. 2009.
|
